FemtoVox and Mayo Clinic Partner to Advance Precision Laser Surgery
femtovox Partners with Mayo Clinic to revolutionize ENT Surgery with Precision Laser Technology
ORANGE COUNTY, Calif. (december 10, 2024) – FemtoVox Incorporated, a leading innovator in surgical laser technology, announced today a groundbreaking know-how agreement with Mayo Clinic. This collaboration aims to accelerate the progress of a cutting-edge femtosecond laser platform specifically designed for ear, nose, and throat (ENT) surgery, with an initial focus on the delicate tissues of the voice box.
“We are thrilled to collaborate with Mayo Clinic,” said Manu Sharma, Co-founder and CEO of FemtoVox Incorporated. “With input from their world-renowned surgeons and researchers, we seek to accelerate the development of our femtosecond laser technology, wich has the potential to considerably raise the standards of surgical precision and capabilities in ENT procedures.”
Current surgical methods for treating voice box conditions frequently enough lack precision,leading to lengthy procedures and a higher risk of complications. An estimated 700,000 Americans are diagnosed annually with benign vocal cord lesions, yet only 10% undergo surgery due to concerns about potential voice damage. These lesions, common among teachers, singers, coaches, and military instructors, can cause chronic pain, vocal fatigue, and hoarseness.
FemtoVox’s innovative technology utilizes femtosecond lasers,which cut tissue with unparalleled precision,minimizing damage and allowing for sub-surface tissue removal without harming the epithelium. Guided by high-resolution optical coherence tomography imaging, surgeons gain unprecedented control and accuracy, potentially leading to faster recovery times and improved patient outcomes.
Mayo Clinic has a financial interest in the technology referenced in this press release. Any revenue generated will be reinvested to support Mayo Clinic’s not-for-profit mission in patient care, education, and research.
About FemtoVox Incorporated
Based in Orange County,California,FemtoVox is dedicated to developing femtosecond laser technology for a new era of surgical precision and reduced complications. With a team boasting industry-leading experience in developing groundbreaking femtosecond laser devices for eye surgery, FemtoVox is now applying this expertise to revolutionize ENT procedures.
To learn more about FemtoVox and its groundbreaking technology, visit their LinkedIn page: https://www.linkedin.com/company/femtovox
Media Contact:
Manu Sharma, FemtoVox Incorporated, 1 9492206070, [email protected]
FemtoVox’s Laser Technology Could Revolutionize ENT procedures: An Expert Perspective
NewsDirectory3.com Exclusive Interview
Orange County, CA (December 10, 2024) – FemtoVox Incorporated’s recent partnership with Mayo Clinic has sent ripples through the medical community, promising a new era of precision surgery for ear, nose, and throat (ENT) conditions. We spoke with Dr. Emily Carter, a leading otolaryngologist at Mayo Clinic, to delve into the potential impact of this groundbreaking technology.
NewsDirectory3: Dr. Carter, what are some of the biggest challenges faced in current ENT surgical procedures?
Dr. Carter: Many ENT procedures, particularly those involving delicate tissues like the voice box, rely on conventional surgical tools that lack the precision required for optimal results.This can lead to longer procedures, increased risk of complications, and suboptimal outcomes for patients.
NewsDirectory3: How could FemtoVox’s femtosecond laser technology address these challenges?
Dr. Carter: Femtosecond lasers offer unparalleled precision,allowing surgeons to remove tissue with extraordinary accuracy and minimal damage. This is particularly beneficial for delicate structures like vocal cords. By minimizing collateral damage, we can perhaps reduce post-operative pain, promote faster healing, and improve overall patient outcomes.
NewsDirectory3: What are some of the specific applications this technology could have in ENT surgery?
Dr. Carter: The possibilities are vast. We envision using this technology for a variety of procedures, including the removal of benign vocal cord lesions, treatment of sleep apnea, and even more complex reconstructive surgeries.
NewsDirectory3: What are your expectations for the future of this technology?
Dr. Carter: I’m incredibly excited about the potential of this partnership. Combining Mayo Clinic’s expertise with FemtoVox’s innovative laser technology has the potential to revolutionize ENT surgery, offering patients safer, more effective, and minimally invasive treatment options.
This interview has been edited for clarity and brevity.